Efficacy and Safety of Once-Daily Inhaled Umeclidinium in Asian Patients with COPD: Results from a Randomized, Placebo-Controlled Study

PURPOSE: Previous studies demonstrating efficacy and safety of once-daily umeclidinium (UMEC) in patients with chronic obstructive pulmonary disease (COPD) have included few Asian patients. This study evaluated efficacy and safety of UMEC 62.5 mcg versus placebo in Asian patients with COPD. PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Nanshan, Zheng, Jinping, Lee, Sang Haak, Lipson, David A, Du, Xin, Wu, Shunquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173840/
https://www.ncbi.nlm.nih.gov/pubmed/32368027
http://dx.doi.org/10.2147/COPD.S215011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173840/
https://www.ncbi.nlm.nih.gov/pubmed/32368027
http://dx.doi.org/10.2147/COPD.S215011

Ejemplares similares